KENNETH WARNER: Open Payments
NPI 1417973231 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 19 payments from 10 companies in 2025. Trend: 2023 $448 · 2024 $168 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $146 |
| Amgen Inc. | 3 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| PFIZER INC. | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: REXULTI, REPATHA, NURTEC ODT, AIRSUPRA, QULIPTA, UBRELVY, NEXIUM, ELIQUIS.
Industry payments across MI — which companies pay providers there.
